Home parenteral nutrition (HPN) refers to long-term feeding methods that directly administer essential nutrients into the bloodstream via peripheral venous access devices like midlines, portacatheters, or implanted ports instead of eating and digesting ordinary foods orally.
The global Home Parenteral Nutrition (HPN) market was valued at US$ 804 million in 2023 and is anticipated to reach US$ 1219.5 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global Home Parenteral Nutrition (HPN) market has been growing steadily in recent years, driven primarily by advancements in technology and increased awareness about the benefits of HPN. However, there have also been challenges faced by companies operating within the space, including regulatory hurdles and competition from alternative forms of treatment.
The market growth can be attributed to rising incidence rates of malnutrition among patients suffering from chronic diseases such as cancer and liver failures, expanding geriatric population with fragile immune systems requiring external nutritional support, and favorable reimbursement scenarios in developed regions worldwide promoting wider adoption of HPN solutions.
The future outlook for the HPN market appears positive given the increasing number of indications covered by HPN, development of new products capable of addressing unmet needs, and strengthening partnerships between key players and third parties to foster better care pathway coordination across diverse territories with varying regulatory environments impacting product availability. With increasing emphasis placed on precision medicine approaches involving personalized nutrition.
This report aims to provide a comprehensive presentation of the global market for Home Parenteral Nutrition (HPN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Home Parenteral Nutrition (HPN).
Report Scope
The Home Parenteral Nutrition (HPN) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Home Parenteral Nutrition (HPN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Home Parenteral Nutrition (HPN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Neonates
Geriatrics
Chronic Disease Patients
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Home Parenteral Nutrition (HPN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Home Parenteral Nutrition (HPN) Market Overview
1.1 Product Overview and Scope of Home Parenteral Nutrition (HPN)
1.2 Home Parenteral Nutrition (HPN) Segment by Type
1.2.1 Global Home Parenteral Nutrition (HPN) Market Value Comparison by Type (2024-2030)
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Home Parenteral Nutrition (HPN) Segment by Application
1.3.1 Global Home Parenteral Nutrition (HPN) Market Value by Application: (2024-2030)
1.3.2 Neonates
1.3.3 Geriatrics
1.3.4 Chronic Disease Patients
1.4 Global Home Parenteral Nutrition (HPN) Market Size Estimates and Forecasts
1.4.1 Global Home Parenteral Nutrition (HPN) Revenue 2019-2030
1.4.2 Global Home Parenteral Nutrition (HPN) Sales 2019-2030
1.4.3 Global Home Parenteral Nutrition (HPN) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Home Parenteral Nutrition (HPN) Market Competition by Manufacturers
2.1 Global Home Parenteral Nutrition (HPN) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Home Parenteral Nutrition (HPN) Average Price by Manufacturers (2019-2024)
2.4 Global Home Parenteral Nutrition (HPN) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Home Parenteral Nutrition (HPN), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Home Parenteral Nutrition (HPN), Product Type & Application
2.7 Home Parenteral Nutrition (HPN) Market Competitive Situation and Trends
2.7.1 Home Parenteral Nutrition (HPN) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Home Parenteral Nutrition (HPN) Players Market Share by Revenue
2.7.3 Global Home Parenteral Nutrition (HPN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Home Parenteral Nutrition (HPN) Retrospective Market Scenario by Region
3.1 Global Home Parenteral Nutrition (HPN) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Home Parenteral Nutrition (HPN) Global Home Parenteral Nutrition (HPN) Sales by Region: 2019-2030
3.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2019-2024
3.2.2 Global Home Parenteral Nutrition (HPN) Sales by Region: 2025-2030
3.3 Global Home Parenteral Nutrition (HPN) Global Home Parenteral Nutrition (HPN) Revenue by Region: 2019-2030
3.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2019-2024
3.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2025-2030
3.4 North America Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
3.4.1 North America Home Parenteral Nutrition (HPN) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Home Parenteral Nutrition (HPN) Sales by Country (2019-2030)
3.4.3 North America Home Parenteral Nutrition (HPN) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
3.5.1 Europe Home Parenteral Nutrition (HPN) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Home Parenteral Nutrition (HPN) Sales by Country (2019-2030)
3.5.3 Europe Home Parenteral Nutrition (HPN) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
3.6.1 Asia Pacific Home Parenteral Nutrition (HPN) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2019-2030)
3.6.3 Asia Pacific Home Parenteral Nutrition (HPN) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
3.7.1 Latin America Home Parenteral Nutrition (HPN) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Home Parenteral Nutrition (HPN) Sales by Country (2019-2030)
3.7.3 Latin America Home Parenteral Nutrition (HPN) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
3.8.1 Middle East and Africa Home Parenteral Nutrition (HPN) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Home Parenteral Nutrition (HPN) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2019-2030)
4.1.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2019-2024)
4.1.2 Global Home Parenteral Nutrition (HPN) Sales by Type (2025-2030)
4.1.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2019-2030)
4.2 Global Home Parenteral Nutrition (HPN) Revenue by Type (2019-2030)
4.2.1 Global Home Parenteral Nutrition (HPN) Revenue by Type (2019-2024)
4.2.2 Global Home Parenteral Nutrition (HPN) Revenue by Type (2025-2030)
4.2.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2019-2030)
4.3 Global Home Parenteral Nutrition (HPN) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2019-2030)
5.1.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2019-2024)
5.1.2 Global Home Parenteral Nutrition (HPN) Sales by Application (2025-2030)
5.1.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2019-2030)
5.2 Global Home Parenteral Nutrition (HPN) Revenue by Application (2019-2030)
5.2.1 Global Home Parenteral Nutrition (HPN) Revenue by Application (2019-2024)
5.2.2 Global Home Parenteral Nutrition (HPN) Revenue by Application (2025-2030)
5.2.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2019-2030)
5.3 Global Home Parenteral Nutrition (HPN) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 B. Braun Melsungen
6.4.1 B. Braun Melsungen Corporation Information
6.4.2 B. Braun Melsungen Description and Business Overview
6.4.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
6.4.5 B. Braun Melsungen Recent Developments/Updates
6.5 Grifols International
6.5.1 Grifols International Corporation Information
6.5.2 Grifols International Description and Business Overview
6.5.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
6.5.5 Grifols International Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.6.1 Otsuka Pharmaceutical Corporation Information
6.6.2 Otsuka Pharmaceutical Description and Business Overview
6.6.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Sichuan Kelun Pharmaceutical
6.9.1 Sichuan Kelun Pharmaceutical Corporation Information
6.9.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.9.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
6.9.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Home Parenteral Nutrition (HPN) Industry Chain Analysis
7.2 Home Parenteral Nutrition (HPN) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Home Parenteral Nutrition (HPN) Production Mode & Process
7.4 Home Parenteral Nutrition (HPN) Sales and Marketing
7.4.1 Home Parenteral Nutrition (HPN) Sales Channels
7.4.2 Home Parenteral Nutrition (HPN) Distributors
7.5 Home Parenteral Nutrition (HPN) Customers
8 Home Parenteral Nutrition (HPN) Market Dynamics
8.1 Home Parenteral Nutrition (HPN) Industry Trends
8.2 Home Parenteral Nutrition (HPN) Market Drivers
8.3 Home Parenteral Nutrition (HPN) Market Challenges
8.4 Home Parenteral Nutrition (HPN) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
*If Applicable.